Moody’s also assigned an ‘A3’ rating to SNCH’s $80.5 million of outstanding debt. The rating reflects SNCH’s favorable market position, low leverage position and manageable fixed rate debt structure.
The outlook revision is based on SNCH’s recent downturn in operating performance and the potential for balance sheet dilution.
More articles on healthcare finance:
South Dakota hospital set to lose Medicare funding over EMTALA violations
8 hospitals’ finances hurt by EHR costs
Washington radiology group renews RCM contract with Zotec
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
